MYGN:NASDAQ
Myriad Genetics Inc
$4.12
arrow_upward
+0.98%(+0.040) 1D
Okt 14, 10:34:48 AM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa MYGN...
Buksan
$4.08
Mataas
$4.19
Mababa
$4.04
Mkt. cap
394.08M
Avg. na dami
2.03M
Dami
87.00K
Mataas nang 52-wk
$8.59
Mababa nang 52-wk
$2.74
EPS
-$1.20
Beta
1.64
Mga natitirang share
95.65M
Bilang ng mga empleyado
3K
Buksan
$4.08
Mataas
$4.19
Mababa
$4.04
Mkt. cap
394.08M
Avg. na dami
2.03M
Dami
87.00K
Mataas nang 52-wk
$8.59
Mababa nang 52-wk
$2.74
EPS
-$1.20
Beta
1.64
Mga natitirang share
95.65M
Bilang ng mga empleyado
3K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Bloomberg.com
·
16 oras ang nakalipas
Stocks, Bonds Fall as CPI Data Fuel Fed-Hike Bets: Markets Wrap
Yahoo Finance
·
6 araw ang nakalipas
These 7 major S&P 500 stocks need to rally at least 200% to reclaim their peaks
The Guardian
·
1 linggo ang nakalipas
S&P 500 and Nasdaq surge to record highs after AI chipmaker rally
TheStreet
·
1 buwan ang nakalipas
UBS revamps S&P 500 target for rest of 2026
Profile
Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to a particular drug therapy, assess a patient's risk of disease progression and disease recurrence, and measure disease activity. Wikipedia
Tungkol sa Myriad Genetics Inc
CEOPaul J. Diaz
Mga Empleyado2.7K
Itinatag1991
HeadquartersLungsod ng Salt Lake, Utah, Estados Unidos
Sektor-
Websitemyriad.com